{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:42:45Z","timestamp":1773157365138,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,1,1]]},"DOI":"10.1038\/sj.bmt.1702091","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:35:32Z","timestamp":1031153732000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["High-dose cyclophosphamide\u2009+\u2009carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma \u2013 a phase II study"],"prefix":"10.1038","volume":"25","author":[{"given":"HC","family":"Toh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SL","family":"McAfee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sackstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Multani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BF","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Garcia-Carbonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Colby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TR","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,1,25]]},"reference":[{"key":"BF1702091_CR1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V92.5.1471","volume":"92","author":"T Guillaume","year":"1998","unstructured":"Guillaume T, Rubenstein DB, Symann M . Immune reconstitution and immunotherapy after hematopoietic stem cell transplantation Blood 1998 92: 1471\u20131490","journal-title":"Blood"},{"key":"BF1702091_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0145-2126(91)90464-5","volume":"9","author":"BS Charak","year":"1991","unstructured":"Charak BS, Malloy B, Agah R et al. Interaction of various cytokines with interkeukin-2 in the generation of killer cells from human bone marrow: application in the purging of leukemia Leukemia Res 1991 9: 801\u2013810","journal-title":"Leukemia Res"},{"key":"BF1702091_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00007890-199307000-00006","volume":"56","author":"BS Charak","year":"1993","unstructured":"Charak BS, Brynes RK, Chogyoji M et al. Graft vesus leukemia effect of interleukin-2 activated bone marrow: correlation with eradication of residual disease Transplantation 1993 56: 31\u201337","journal-title":"Transplantation"},{"key":"BF1702091_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.bmt.1700954","volume":"20","author":"KR Meehan","year":"1997","unstructured":"Meehan KR, Verma UN, Cahill R et al. Interleukin-2-activated hematopoietic stem cell transplantation for breastcancer: investigation of dose level with clinical correlates Bone Marrow Transplant 1997 20: 643\u2013651","journal-title":"Bone Marrow Transplant"},{"key":"BF1702091_CR5","first-page":"2015","volume":"51","author":"BS Charak","year":"1991","unstructured":"Charak BS, Brynes RK, Katsuda S et al. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin-2 therapy Cancer Res 1991 51: 2015\u20132020","journal-title":"Cancer Res"},{"key":"BF1702091_CR6","first-page":"pp 35","volume-title":"Immunotherapy and Bone Marrow Transplantation","author":"BS Charak","year":"1995","unstructured":"Charak BS, Verma UN, Mazumder A . Immunomodulation in autologous bone marrow transplantation: experimental approaches. In: Spitzer T, Mazumder A (eds) Immunotherapy and Bone Marrow Transplantation Futura: Armonk, NY 1995 pp 35\u201358"},{"key":"BF1702091_CR7","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.4049\/jimmunol.143.9.3093","volume":"143","author":"R Agah","year":"1989","unstructured":"Agah R, Malloy B, Kerner M et al. Generation and characterization of IL-2 activated bone marrow cells as potent graft versus tumor effectors in transplantation J Immunol 1989 143: 3093\u20133099","journal-title":"J Immunol"},{"key":"BF1702091_CR8","first-page":"28","volume":"6","author":"KR Meehan","year":"1996","unstructured":"Meehan KR, Verma UN, Rajagopal C et al. Stem cell transplantation with chemoradiotherapy myeloablation and interleukin-2 J Infus Chemother 1996 6: 28\u201332","journal-title":"J Infus Chemother"},{"key":"BF1702091_CR9","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1001\/jama.1986.03380220083027","volume":"256","author":"MT Lotze","year":"1986","unstructured":"Lotze MT, Chang AE, Seipp CA et al. High dose recombinant IL-2 in the treatment of patients with disseminated cancer JAMA 1986 256: 3117\u20133124","journal-title":"JAMA"},{"key":"BF1702091_CR10","first-page":"537","volume":"15","author":"TR Spitzer","year":"1995","unstructured":"Spitzer TR, Cirenza E, McAfee S et al. Phase I\u2013II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue Bone Marrow Transplant 1995 15: 537\u2013542","journal-title":"Bone Marrow Transplant"},{"key":"BF1702091_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Non parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF1702091_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2307\/2344317","volume":"35","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J . Asymmetrically efficient rank invariant test procedures J R Stat Soc A 1972 35: 185\u2013206","journal-title":"J R Stat Soc A"},{"key":"BF1702091_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life tables J R Stat Soc B 1972 34: 187\u2013220","journal-title":"J R Stat Soc B"},{"key":"BF1702091_CR14","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJM199810013391407","volume":"339","author":"GN Hortobagyi","year":"1998","unstructured":"Hortobagyi GN . Treatment of breast cancer New Engl J Med 1998 339: 974\u2013984","journal-title":"New Engl J Med"},{"key":"BF1702091_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<104::AID-CNCR15>3.0.CO;2-R","volume":"85","author":"ZU Rahman","year":"1999","unstructured":"Rahman ZU, Frye DK, Smith TL et al. Results and long-term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy Cancer 1999 85: 104\u2013111","journal-title":"Cancer"},{"key":"BF1702091_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.bmt.1700687","volume":"19","author":"N Robinson","year":"1997","unstructured":"Robinson N, Benyunes MC, Thompson JA et al. Interleukin-2 after autologous stem cell transplantation for hematologic malignancy \u2013 a phase I\/II study Bone Marrow Transplant 1997 19: 435\u2013442","journal-title":"Bone Marrow Transplant"},{"key":"BF1702091_CR17","first-page":"34","volume":"3","author":"JS Miller","year":"1997","unstructured":"Miller JS, Tessmer-Tuck J, Pierson BA et al. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer activity Biol Blood Marrow Transplant 1997 3: 34\u201344","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1702091_CR18","first-page":"493","volume":"2","author":"RJ Soiffer","year":"1996","unstructured":"Soiffer RJ, Murray C, Shapiro C et al. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2 Clin Cancer Res 1996 2: 493\u2013499","journal-title":"Clin Cancer Res"},{"key":"BF1702091_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.bmt.1701520","volume":"23","author":"EM Areman","year":"1999","unstructured":"Areman EM, Mazumder A, Kotula PL et al. Hematopoietic potential of IL-2 cultured peripheral blood stem cells from breast cancer patients Bone Marrow Transplant 1999 23: 27\u201333","journal-title":"Bone Marrow Transplant"},{"key":"BF1702091_CR20","first-page":"pp 189","volume-title":"Cancer Chemotherapy and Biological Response Modifiers Annual 16","author":"WC Kopp","year":"1996","unstructured":"Kopp WC, Holmlund JT . Cytokines and immunological monitoring. In Pinedo HM, Longo DL, Chabner BA (eds) Cancer Chemotherapy and Biological Response Modifiers Annual 16 Elsevier Science BV: Amsterdam 1996 pp 189\u2013238"},{"key":"BF1702091_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.bmt.1701520","volume":"23","author":"R Salazar","year":"1999","unstructured":"Salazar R, Sola C, Maroto P et al. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1999 23: 27\u201333","journal-title":"Bone Marrow Transplant"},{"key":"BF1702091_CR22","first-page":"35","volume":"26","author":"CA Hudis","year":"1999","unstructured":"Hudis CA, Munster PN . High-dose therapy for breast cancer Semin Oncol 1999 26: 35\u201347","journal-title":"Semin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702091","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:19:35Z","timestamp":1733570375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1,1]]}},"alternative-id":["BF1702091"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702091","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1,1]]},"assertion":[{"value":"13 May 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}